This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Diuretic Renal Scintigraphy Protocol Considerations
- 99mTc(CO)3(NTA) and 131I-OIH: Comparable Plasma Clearances in Patients with Chronic Kidney Disease
- Synthesis and In Vivo Evaluation of p-18F-Fluorohippurate as a New Radiopharmaceutical for Assessment of Renal Function by PET
- Prevention of diabetic nephropathy in Ins2+/-AkitaJ mice by the mitochondria-targeted therapy MitoQ
- 99mTc(CO)3(NTA): A 99mTc Renal Tracer with Pharmacokinetic Properties Comparable to Those of 131I-OIH in Healthy Volunteers
- Development of a Novel 99mTc-Chelate-Conjugated Bisphosphonate with High Affinity for Bone as a Bone Scintigraphic Agent
- Effect of Solvent Flow Rate in Mini-Column Testing of 99mTc-Mertiatide
- 99mTc-MAEC Complexes: New Renal Radiopharmaceuticals Combining Characteristics of 99mTc-MAG3 and 99mTc-EC
- Transport of 99mTc-MAG3 via Rat Renal Organic Anion
- Transport of 99mTc-MAG3 via Rat Renal Organic Anion Transporter 1
- A Comparison in Monkeys of 99mTc Labeled to a Peptide by 4 Methods
- Effect of Protein Binding on Renal Extraction of 131I-OIH and 99mTc-Labeled Tubular Agents
- Metal compounds in therapy and diagnosis